[HTML][HTML] Quality-of-life effects of prostate-specific antigen screening
EAM Heijnsdijk, EM Wever, A Auvinen… - … England Journal of …, 2012 - Mass Medical Soc
Background After 11 years of follow-up, the European Randomized Study of Screening for
Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men …
Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men …
Quality-of-life effects of prostate-specific antigen screening.
EA Heijnsdijk, EM Wever, A Auvinen… - The New England …, 2012 - europepmc.org
Background After 11 years of follow-up, the European Randomized Study of Screening for
Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men …
Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men …
[PDF][PDF] Quality-of-Life Effects of Prostate-Specific Antigen Screening
EAM Heijnsdijk, EM Wever, A Auvinen, J Hugosson… - N Engl J …, 2012 - swopresearch.nl
Quality-of-Life Effects of Prostate-Specific Antigen Screening Page 1 n engl j med 367;7
nejm.org august 16, 2012 595 The new england journal of medicine established in 1812 august …
nejm.org august 16, 2012 595 The new england journal of medicine established in 1812 august …
Quality-of-Life Effects of Prostate-Specific Antigen Screening
EAM Heijnsdijk, SM Moss, M Zappa… - New England Journal …, 2012 - hero.epa.gov
BackgroundAfter 11 years of follow-up, the European Randomized Study of Screening for
Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men …
Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men …
[PDF][PDF] quality of life effects of prostate-specific antigen screening
EAM Heijnsdijk, EM Wever, A Auvinen… - Effects of Prostate …, 2012 - repub.eur.nl
Background The European Randomized Study of Screening for Prostate Cancer (ERSPC)
reported a 29% prostate cancer mortality reduction among screened men after 11 years …
reported a 29% prostate cancer mortality reduction among screened men after 11 years …
[PDF][PDF] Quality-of-Life Effects of Prostate-Specific Antigen Screening
EAM Heijnsdijk, EM Wever, A Auvinen, J Hugosson… - N Engl J Med, 2012 - med.unipmn.it
Quality-of-Life Effects of Prostate-Specific Antigen Screening Page 1 n engl j med 367;7
nejm.org august 16, 2012 595 The new england journal of medicine established in 1812 august …
nejm.org august 16, 2012 595 The new england journal of medicine established in 1812 august …
Quality-of-life effects of prostate-specific antigen screening
EAM Heijnsdijk, EM Wever, A Auvinen… - NEW ENGLAND …, 2012 - researchportal.tuni.fi
Background: After 11 years of follow-up, the European Randomized Study of Screening for
Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men …
Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men …
[PDF][PDF] quality of life effects of prostate-specific antigen screening
EAM Heijnsdijk, EM Wever, A Auvinen… - Effects of Prostate …, 2012 - core.ac.uk
Background The European Randomized Study of Screening for Prostate Cancer (ERSPC)
reported a 29% prostate cancer mortality reduction among screened men after 11 years …
reported a 29% prostate cancer mortality reduction among screened men after 11 years …
[HTML][HTML] Quality-of-life effects of prostate-specific antigen screening
EAM Heijnsdijk, EM Wever, A Auvinen… - The New England …, 2012 - ncbi.nlm.nih.gov
Background The European Randomized Study of Screening for Prostate Cancer (ERSPC)
reported a 29% prostate cancer mortality reduction among screened men after 11 years …
reported a 29% prostate cancer mortality reduction among screened men after 11 years …
Quality-of-life effects of prostate-specific antigen screening
EAM Heijnsdijk, EM Wever… - The New England …, 2012 - pubmed.ncbi.nlm.nih.gov
Background After 11 years of follow-up, the European Randomized Study of Screening for
Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men …
Prostate Cancer (ERSPC) reported a 29% reduction in prostate-cancer mortality among men …